-
13241por Shiryaev, Sergey A., Thomsen, Elliot R., Cieplak, Piotr, Chudin, Eugene, Cheltsov, Anton V., Chee, Mark S., Kozlov, Igor A., Strongin, Alex Y.“…BACKGROUND: The hepatitis C virus (HCV) genome encodes a long polyprotein, which is processed by host cell and viral proteases to the individual structural and non-structural (NS) proteins. …”
Publicado 2012
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
13242por McDermott, Jason E, Diamond, Deborah L, Corley, Courtney, Rasmussen, Angela L, Katze, Michael G, Waters, Katrina M“…We present topological analysis of co-abundance networks as an alternative to differential regulation for confident identification of target proteins from two related global proteomics studies of hepatitis C virus (HCV) infection. RESULTS: We analyzed global proteomics data sets from a cell culture study of HCV infection and from a clinical study of liver biopsies from HCV-positive patients. …”
Publicado 2012
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
13243“…Accurate PAMP discrimination is essential to avoid self recognition that can generate autoimmunity, and therefore should be facilitated by the presence of multiple motifs in a PAMP that mark it as non-self. Hepatitis C virus (HCV) RNA is recognized as non-self by RIG-I through the presence of a 5′-triphosphate (5′-ppp) on the viral RNA in association with a 3′ poly-U/UC tract. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
13244“…The most common chronic illnesses reported were active drug addiction or recovery (and their associated symptoms), depression, arthritis, and hepatitis C. Participants identified life transitions as being the root cause for not having a family doctor. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
13245por Chen, Chih-Hung, Chang, Li-Teh, Tung, Wei-Chih, Chen, Yung-Lung, Chang, Chia-Lo, Leu, Steve, Sun, Cheuk-Kwan, Tsai, Tzu-Hsien, Tsai, I-Ting, Chang, Hsueh-Wen, Yip, Hon-Kan“…Chronic hepatitis B and esophageal varices bleeding were independently, whereas chronic hepatitis C, elevated aspartate aminotransferase (AST), and decompensated LC were inversely and independently correlated with circulating EPC level (all p < 0.03). …”
Publicado 2012
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
13246por Kim, Tae Wan, Kim, Hong Joo, Chon, Chang Uk, Won, Hyun Sun, Park, Jung Ho, Park, Dong Il, Cho, Yong Kyun, Sohn, Chong Il, Jeon, Woo Kyu, Kim, Byung Ik“…RESULTS: The causes of liver cirrhosis were alcohol (n=109, 39.9%), hepatitis B virus (n=125, 45.8%), hepatitis C virus (n=20, 7.3%), and cryptogenic (n=19, 7.0%). …”
Publicado 2012
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
13247por Pripuzova, Natalia, Wang, Richard, Tsai, Shien, Li, Bingjie, Hung, Guo-Chiuan, Ptak, Roger G., Lo, Shyh-Ching“…FINDINGS: We developed a real-time PCR array capable of simultaneously detecting eight human viral pathogens: human immunodeficiency virus types 1 and 2 (HIV-1 and -2), hepatitis B virus (HBV), hepatitis C virus (HCV), human T-cell leukemia virus-1 and -2 (HTLV-1 and -2), vaccinia virus (VACV) and West Nile virus (WNV). …”
Publicado 2012
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
13248por Horberg, Michael A, Hurley, Leo B, Towner, William J, Allerton, Michael W, Tang, Beth T, Catz, Sheryl L, Silverberg, Michael J, Quesenberry, Charles P“…We assessed associations by utilizing mixed modeling analyses (clustered by provider and medical center), controlling for patient age, sex, race/ethnicity, HIV risk behavior, hepatitis C coinfection, ART regimen class, and calendar year. …”
Publicado 2012
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
13249por De Marco, Laura, Manzini, Paola, Trevisan, Morena, Gillio-Tos, Anna, Danielle, Franca, Balloco, Cinzia, Pizzi, Alessandra, De Filippo, Eleonora, D’Antico, Sergio, Violante, Beatrice, Valfrè, Adriano, Curti, Franco, Merletti, Franco, Richiardi, Lorenzo“…BACKGROUND: Occult hepatitis C virus infection (OCI) is a recently described phenomenon characterized by undetectable levels of HCV-RNA in serum/plasma by current laboratory assays, with identifiable levels in peripheral blood mononuclear cells (PBMCs) and/or liver tissue by molecular tests with enhanced sensitivity. …”
Publicado 2012
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
13250por op den Winkel, Mark, Nagel, Dorothea, Sappl, Julia, op den Winkel, Philip, Lamerz, Rolf, Zech, Christoph J., Straub, Gundula, Nickel, Thomas, Rentsch, Markus, Stieber, Petra, Göke, Burkhard, Kolligs, Frank T.“…Alcoholic cirrhosis (44.4%) was the leading etiological factor followed by viral hepatitis C (18.8%). Median survival was 18.1 months (95%-CI: 15.2–22.2). …”
Publicado 2012
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
13251por Dolganiuc, Angela, Kodys, Karen, Marshall, Christopher, Saha, Banishree, Zhang, Shuye, Bala, Shashi, Szabo, Gyongyi“…BACKGROUND & AIMS: Hepatitis C virus (HCV) is difficult to eradicate and type III interferons (IFN-λ, composed of IL-28A, IL-28B and IL-29) are novel therapeutic candidates. …”
Publicado 2012
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
13252por Arnold, Jamie J., Sharma, Suresh D., Feng, Joy Y., Ray, Adrian S., Smidansky, Eric D., Kireeva, Maria L., Cho, Aesop, Perry, Jason, Vela, Jennifer E., Park, Yeojin, Xu, Yili, Tian, Yang, Babusis, Darius, Barauskus, Ona, Peterson, Blake R., Gnatt, Averell, Kashlev, Mikhail, Zhong, Weidong, Cameron, Craig E.“…Development of antiviral ribonucleosides for treatment of hepatitis C virus (HCV) infection has been hampered by appearance of toxicity during clinical trials that evaded detection during preclinical studies. …”
Publicado 2012
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
13253por Oh, Jin-Kyoung, Shin, Hai-Rim, Lim, Min Kyung, Cho, Heeyoun, Kim, Dong-Il, Jee, Youngmee, Yun, Haesun, Yoo, Keun-Young“…BACKGROUND: There has been limited study on the effect of infection with different hepatitis C virus (HCV) genotypes on the risk of hepatocellular carcinoma (HCC) in hepatitis B virus (HBV) endemic regions of Asia. …”
Publicado 2012
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
13254por Batista-dos-Santos, Sergio, Raiol, Milene, Santos, Sidney, Cunha, Maristela G, Ribeiro-dos-Santos, Ândrea“…This percentage was higher than the altered serological results (reactive or inconclusive) of the prevalence of anti-HIV (0.67%), anti-hepatitis C virus (0.34%), anti-hepatitis B surface antigen (0.67%), anti-human T-lymphotropic virus I/II (1.18%), anti-Chagas disease (0.17%) and syphilis (VDRL) (0.50%), but not higher than anti-hepatitis B core antigen antibodies (4.37%). …”
Publicado 2012
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
13255por Kong, Yuan, Wang, Xiaoping, Shang, Yushu, Schroder, Paul M., Liang, Wenhua, Ling, Xiaoting, Guo, Zhiyong, He, Xiaoshun“…BACKGROUND: Chronic hepatitis C virus (HCV) infection is one of the leading causes of hepatic cirrhosis and hepatocellular carcinoma, and HCV genotype 1 is the most prevalent genotype and is resistant to current standard therapy. …”
Publicado 2012
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
13256por Uno, Kazuko, Yagi, Katsumi, Yoshimori, Masayo, Tanigawa, Mari, Yoshikawa, Toshikazu, Fujita, Setsuya“…PARTICIPANTS: 295 healthy individuals (159 males and 136 females) without a history of cancer, autoimmune diseases and hepatitis C virus (HCV) whose IFN-α production was quantified more than five times within 24 years were selected. …”
Publicado 2013
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
13257por Klimas, Jan, Field, Catherine-Anne, Cullen, Walter, O’Gorman, Clodagh SM, Glynn, Liam G, Keenan, Eamon, Saunders, Jean, Bury, Gerard, Dunne, Colum“…It is also an important factor in poor prognosis among drug users with hepatitis C virus (HCV) as it impacts progression to hepatic cirrhosis or opiate overdose in opioid users. …”
Publicado 2013
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
13258por Khan, Faisal S., Lotia-Farrukh, Ismat, Khan, Aamir J., Siddiqui, Saad Tariq, Sajun, Sana Zehra, Malik, Amyn Abdul, Burfat, Aziza, Arshad, Mohammad Hussham, Codlin, Andrew J., Reininger, Belinda M., McCormick, Joseph B., Afridi, Nadeem, Fisher-Hoch, Susan P.“…At the same time, infectious diseases such as hepatitis B (24%) and hepatitis C (8%) were prevalent in this population. …”
Publicado 2013
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
13259por Toyoda, Hidenori, Kumada, Takashi, Shimada, Noritomo, Takaguchi, Koichi, Ide, Tatsuya, Sata, Michio, Ginba, Hiroyuki, Matsuyama, Kazuhiro, Izumi, Namiki“…BACKGROUND: The importance of the reduction in hepatitis C virus (HCV) RNA levels 4 and 12 weeks after starting peginterferon (PEG-IFN) and ribavirin combination therapy has been reported to predict a sustained virologic response (SVR) in patients infected with HCV genotype 1. …”
Publicado 2012
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
13260por Hardy, Gareth A. D., Sieg, Scott, Rodriguez, Benigno, Anthony, Donald, Asaad, Robert, Jiang, Wei, Mudd, Joseph, Schacker, Timothy, Funderburg, Nicholas T., Pilch-Cooper, Heather A., Debernardo, Robert, Rabin, Ronald L., Lederman, Michael M., Harding, Clifford V.“…Plasma IFN-I levels correlated inversely with CD4 T cell count (p = 0.003) and positively with levels of plasma HIV-1 RNA and CD38 expression on CD8 T cells (p = 0.009). In hepatitis C virus-infected subjects, treatment with IFN-I and ribavirin increased expression of CD38 on CD8 T cells (p = 0.003). …”
Publicado 2013
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto